Cardiovascular diseases and erectile dysfunction: The two faces of the coin of androgen deficiency

Andrologia

Volumn 43, Issue 1, 2011, Pages 1-8

  Yassin, A A ^a   Akhras, F ^b,c   El Sakka, A I ^d   Saad, F ^e,f  

^a Segeberger Kliniken   (Germany)

^b CROMWELL HOSPITAL   (United Kingdom)

^c Cardiac and Medical Healthcare Services   (United Kingdom)

^d Suez Canal University Faculty of Medicine   (Egypt)

^e Scientific Affairs Men's Healthcare   (Germany)

^f GULF MEDICAL UNIVERSITY   (United Arab Emirates)

Author keywords

Cardiovascular disease; Erectile dysfunction; Metabolic syndrome; Testosterone

Indexed keywords

ANDROGEN; SILDENAFIL; TADALAFIL; TESTOSTERONE;

ANDROGEN DEFICIENCY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; ERECTILE DYSFUNCTION; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; SEXUAL FUNCTION;

ANDROGENS; CARDIOVASCULAR DISEASES; ERECTILE DYSFUNCTION; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 78651247085     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2009.01021.x     Document Type: Article

References (93)

1. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI (2006) The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Med J Aust 185:424-427.
2. Allan CA, Strauss BJ, McLachlan RI (2007) Body composition, metabolic syndrome and testosterone in ageing men. Int J Impotence Res 19:448-457.
3. Aversa A, Isidori AM, De Martino MU, Caprio M, Fabbrini E, Rocchietti- March M, Frajese G, Fabbri A (2000) Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 53:517-522.
4. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A (2003) Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 58:632-638.
5. Azadzoi KM, Kim N, Brown ML, Goldstein I, Cohen RA, Saenz de Tejada I (1992) Endothelium- derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 147:220-225.
6. Bancroft J, Wu FC (1983) Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 12:59-66.
7. Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW (2005) Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2:96-103.
8. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS (2006) Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen- deprivation therapy. Cancer 106:581-588.
9. Blouin K, Despres JP, Couillard C, Tremblay A, Prud'homme D, Bouchard C, Tchernof A (2005) Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 54:1034-1040.
10. Braga- Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, Basaria S (2006) Metabolic syndrome in men with prostate cancer undergoing long- term androgen- deprivation therapy. J Clin Oncol 24:3979-3983.
11. Burnett A (2004) Novel nitric oxide signaling mechanisms regualte the erectile response. Int J Impot Res 16:15-19.
12. Buvat J, Bou Jaoude G (2008) Combination therapy with phosphodiesterase type V inhibitors and testosterone. Curr Sex Health Rep 5:135-140.
13. Corona G, Forti G, Maggi M (2008) Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome Aging Male 11:193-199.
14. Corona G, Mannucci E, Forti G, Maggi M (2009a) Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting CVDs. Int J Androl 32:74-80.
15. Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G, Forti G, Maggi M (2009b) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6:285-293.
16. Davey Smith G, Frankel S, Yarnell J (1997) Sex and death: are they related? Findings from the Caerphilly cohort study BMJ Clin Res Ed 315:1641-1644.
17. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-1428.
18. El- Sakka AI, Hassoba HM (2006) Age- related testosterone depletion in patients with erectile dysfunction. J Urol 176:2589-2593.
19. El- Sakka AI, Morsy AM (2004) Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography. Urology 64:346-350.
20. El- Sakka AI, Morsy AM, Fagih BI, Nassar AH (2004) Coronary artery risk factors in patients with erectile dysfunction. J Urol 172:251-254.
21. El- Sakka AI, Sayed HM, Tayeb KA (2008) Diabetes- associated androgen alteration in patients with erectile dysfunction. Int J Androl 31:602-608.
22. El- Sakka AI, Sayed HM, Tayeb KA (2009) Androgen pattern in patients with II diabetes- associated erectile dysfunction: Impact of metabolic control. Urology, 74: 552-560.
23. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D (2004a) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978-2984.
24. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D (2004b) Effect of a mediterranean- style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440-1446.
25. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30:328-338.
26. Foresta C, Caretta N, Rossato M, Garolla A, Ferlin A (2004) Role of androgens in erectile function. J Urol 171:2358-2362. quiz 2435.
27. Fung MM, Bettencourt R, Barrett- Connor E (2004) Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study. J Am Coll Cardiol 43:1405-1411.
28. Gooren LJ, Saad F (2006) Recent insights into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 8:3-9.
29. Guay AT, Perez JB, Jacobson J, Newton RA (2001) Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 22:793-797.
30. Haidar A, Yassin A, Saad F, Shabsigh R (2007) Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male 10:189-196.
31. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, Handelsman DJ, de Kretser DM (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle- aged and older Australian men. Lancet 366:218-224.
32. Hwang TI, Chen HE, Tsai TF, Lin YC (2006) Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res 18:400-404.
33. Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A, Fabbri A (1999) Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 84:3673-3680.
34. Jackson G (2009) Sexual response in CVD. J Sex Res 46:233-236.
35. Jones TH, Saad F (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis. (unpublished data).
36. Jones RD, Nettleship JE, Kapoor D, Jones HT, Channer KS (2005) Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 5:141-154.
37. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P, Tuomilehto J (2005) Sex hormone- binding globulin and insulin- like growth factor- binding protein- 1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 90:1550-1556.
38. Kalyani RR, Dobs AS (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 14:226-234.
39. Kaplan SA, Meehan AG, Shah A (2006) The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?. J Urol 176:1524-1527. discussion 1527-1528.
40. Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876.
41. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, CVD, and cancer in men. European Prospective Investigation Into Cancer in Norfolk (EPIC- Norfolk) Prospective Population Study. Circulation 116: 2694-2701
42. Koulikov D, Fridmans A, Chertin B, Shenfeld O, Farkas A, Spitz IM (2007) Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male? J Urol 177:2267-2271.
43. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006a) Low sex hormone- binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91:843-850.
44. Kupelian V, Shabsigh R, Araujo AB, O'Donnell AB, McKinlay JB (2006b) Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts male aging study. J Urol 176:222-226.
45. Kurbatov D, Kuznetsky J, Traish A (2008) Testosterone improves erectile function in hypogonadal patients with venous leakage. J Androl 29:630-637.
46. Laaksonen DE, Kainulainen S, Rissanen A, Niskanen L (2003a) Relationships between changes in abdominal fat distribution and insulin sensitivity during a very low calorie diet in abdominally obese men and women. Nutr Metab Cardiovasc Dis 13:349-356.
47. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT (2003b) Sex hormones, inflammation and the metabolic syndrome: a population- based study. Eur J Endocrinol 149:601-608.
48. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT (2004) Testosterone and sex hormone- binding globulin predict the metabolic syndrome and diabetes in middle- aged men. Diabetes Care 27:1036-1041.
49. Laughlin GA, Barrett- Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68-75.
50. Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros- Neto G (2000) Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes Relat Metab Disord 24:1433-1437.
51. Liu PY, Death AK, Handelsman DJ (2003) Androgens and CVD. Endocr Rev 24:313-340.
52. Lyon CJ, Law RE, Hsueh WA (2003) Minireview: adiposity, inflammation and atherogenesis. Endocrinology 144:2195-2200.
53. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, Guralnik JM, Basaria S, Valenti G, Ferrucci L (2007) Relationship between low levels of anabolic hormones and 6- year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 167:2249-2254.
54. Mohr BA, Bhasin S, Link CL, O'Donnell AB, McKinlay JB (2006) The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts male aging study. Eur J Endocrinol 155:443-452.
55. Morales A (2003) An integral view of the neuroendocrine aspects of male sexual dysfunction and aging. Can J Urol 10:1777-1779.
56. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M (2004) Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145:2253-2263.
57. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT (2005) Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90:2618-2623.
58. Nacci C, Tarquinio M, Montagnani M (2009) Molecular and clinical aspects of endothelial dysfunction in diabetes. Intern Emerg Med 4:107-116.
59. Park K, Ku JH, Kim SW, Paick JS (2005) Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int 95:366-370.
60. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ (2005) Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 90:2636-2641.
61. Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16:94-112.
62. Rochira V, Balestrieri A, Madeo B, Granata AR, Carani C (2006) Sildenafil improves sleep- related erections in hypogonadal men: evidence from a randomized, placebo- controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections. J Androl 27:165-175.
63. Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 92: 3568-3572
64. Rosenthal BD, May NR, Metro MJ, Harkaway RC, Ginsberg PC (2006) Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology 67:571-574.
65. Shabsigh R (1997) The effects of testosterone on the cavernous tissue and erectile function. World J Urol 15:21-26.
66. Shabsigh R (2004) Testosterone therapy in erectile dysfunction. Aging Male 7:312-318.
67. Shabsigh R, Katz M, Yan G, Makhsida N (2005) Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol 96:67M-72M.
68. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, Buvat J (2006) The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract 60:1087-1092.
69. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M (2008a) Sexual health as a portal to men's health: a problem turned around into an opportunity. Int J Clin Pract 62:179-181.
70. Shabsigh R, Shah M, Sand M (2008b) Erectile dysfunction and men's health: developing a comorbidity risk calculator. J Sex Med 5:1237-1243.
71. Shamloul R, Ghanem H, Fahmy I, El- Meleigy A, Ashoor S, Elnashaar A, Kamel I (2005) Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study. J Sex Med 2:559-564.
72. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR (2004) Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc 52:2077-2081.
73. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166:1660-1665.
74. Smith RMLH, Nathan DM (2006) Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 91:1305-1308.
75. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB (2000) Testosterone, sex hormone- binding globulin, and the development of II diabetes in middle- aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23:490-494.
76. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R (2004) Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 19:657-663.
77. Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP (2007) Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer. J Urol 178:2521-2525.
78. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I (1999) Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140:1861-1868.
79. Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, Huang YH, Goldstein I (2003) Effects of medical or surgical castration on erectile function in an animal model. J Androl 24:381-387.
80. Traish AM, Toselli P, Jeong SJ, Kim NN (2005) Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno- occlusive dysfunction in androgen deficiency. J Androl 26:242-248.
81. Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52:54-70.
82. Traish AM, Guay A, Feeley R, Saad F (2009a) The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 30:10-22.
83. Traish AM, Saad F, Guay A (2009b) The dark side of testosterone deficiency: II. II diabetes and insulin resistance. J Androl 30:23-32.
84. Travison TG, Shabsigh R, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB (2007) The natural progression and remission of erectile dysfunction: results from the Massachusetts male aging study. J Urol 177:241-246.
85. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355.
86. Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Rev 24:183-217.
87. Yassin AA, Saad F (2005) Modulation of erectile function with long acting testosterone injection (Nebido) i.m. in hypogonadal patients. Int J Androl 28 (Suppl. 1):53 (abstract).
88. Yassin AA, Saad F (2006) Dramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literature. Andrologia 38:34-37.
89. Yassin AA, Saad F, Diede HE (2006a) Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open- label uncontrolled study. Andrologia 38:61-68.
90. Yassin AA, Saad F, Traish A (2006b) Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports. J Sex Med 3:727-735.
91. Yassin AA, Saad F, Gooren LJ (2008) Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia 40:259-264.
92. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92:4254-4259.
93. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G, Maggi M (2005) Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 47:409-416. discussion 416.